Consolidated figures
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin % | 97.9% | — | — | — |
| EBITDA margin % | -15.4% | 5.5% | -51.6% | -13.4% |
| EBIT margin % | -15.6% | 5.2% | -51.8% | -13.5% |
| PAT margin % | 1.5% | 5.1% | -49.9% | 4.9% |
| Working capital | ||||
| Receivable days | 1,612 | 2,963 | 2,246 | 2,751 |
| Inventory days | 0 | 0 | 0 | 0 |
| Payable days | 30,340 | 1,227 | 683 | 1,336 |
| NWC days | -28,728 | 1,736 | 1,563 | 1,416 |
| Leverage | ||||
| Current ratio | 1.44 | 1.56 | 1.49 | 1.48 |
| Debt to EBITDA | — | 0 | — | — |
| Debt to equity | 0 | 0 | 0 | 0 |
| Interest coverage | 1.6 | 2.2 | -69.1 | — |
| Asset turnover | 0.13 | 0.07 | 0.1 | 0.09 |
| Return ratios | ||||
| Return on assets % | 0.2% | 0.4% | -5.2% | 0.5% |
| Return on capital employed % | 1.2% | 1.4% | -9.4% | 0.9% |
| Return on equity % | 0.3% | 0.6% | -9.4% | 0.9% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.